-
A model based on machine learning for the prediction of cyclosporin A trough concentration in Chinese allo-HSCT patients
Author: Song, Lin; Huang, Chen-Rong; Pan, Shi-Zheng; Zhu, Jian-Guo; Cheng, Zong-Qi; Yu, Xun; Xue, Ling; Xia, Fan; Zhang, Jin-Yuan; Wu, De-Pei; Miao, Li-Yan
Journal: EXPERT REVIEW OF CLINICAL PHARMACOLOGY. 2023; Vol. 16, Issue 1, pp. 83-91. DOI: 10.1080/17512433.2023.2142561
-
Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review
Author: Ruan, Zhen; Jiang, Yixuan; Shi, Honghao; Jia, Ruxu; Ung, Carolina Oi Lam; Hu, Hao
Journal: EXPERT REVIEW OF CLINICAL PHARMACOLOGY. 2023; Vol. 16, Issue 2, pp. 161-176. DOI: 10.1080/17512433.2023.2174099
-
Optimizing ganciclovir and valganciclovir dosing regimens in pediatric patients with cytomegalovirus infection: a spotlight on therapeutic drug monitoring
Author: Li, Qiu-Yue; van den Anker, John; Wu, Yue-E; Hao, Guo-Xiang; Zhao, Wei
Journal: EXPERT REVIEW OF CLINICAL PHARMACOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1080/17512433.2023.2181161
-
Efficacy and safety of PARP inhibitors in the treatment of BRCA-mutated breast cancer: an updated systematic review and meta-analysis of randomized controlled trials
Author: Sun, Xiaoyu; Xu, Suying; Li, Yiming; Lv, Xuemei; Wei, Minjie; He, Miao
Journal: EXPERT REVIEW OF CLINICAL PHARMACOLOGY. 2023; Vol. 16, Issue 3, pp. 245-256. DOI: 10.1080/17512433.2023.2188193
-
Comparing the bioequivalence and safety of liraglutide in healthy Chinese subjects: an open, single-dose, randomized, repeated, two-sequence, two-cycle phase I clinical trial
Author: Xu, Zhongnan; Liu, Zhengzhi; Wang, Yanli; Xue, Jinling; Chang, Tianying; Cui, Yingzi; Cheng, Yang; Liu, Guangwen; Wang, Wanhua; Zhou, Yannan; Yu, Shuang; Ren, Qing; Yang, Wei; Qu, Xinyao; Chen, Jiahui; Chen, Xuesong; Deng, Qiaohuan; Yang, Haimiao; Wang, Xiuge
Journal: EXPERT REVIEW OF CLINICAL PHARMACOLOGY. 2023; Vol. 16, Issue 4, pp. 363-370. DOI: 10.1080/17512433.2023.2188192
-
A cost-effectiveness analysis of first-line toripalimab plus chemotherapy in advanced nonsquamous non-small cell lung cancer in China
Author: Zheng, Zhiwei; Zhu, Gaofeng; Cao, Xueqiong; Cai, Hongfu; Zhu, Huide
Journal: EXPERT REVIEW OF CLINICAL PHARMACOLOGY. 2023; Vol. 16, Issue 3, pp. 267-273. DOI: 10.1080/17512433.2023.2188194
-
Germline genetic variations in methotrexate pathway are associated with pharmacokinetics, outcome, and toxicity in patients with primary central nervous system lymphoma
Author: Wu, Zhuo; Li, Ziran; Qiu, Xiaoyan; Zhong, Mingkang; Ding, Tianling
Journal: EXPERT REVIEW OF CLINICAL PHARMACOLOGY. 2023; Vol. 16, Issue 4, pp. 371-381. DOI: 10.1080/17512433.2023.2194630
-
Therapeutic drug monitoring of carbapenem antibiotics in critically ill patients: an overview of principles, recommended dosing regimens, and clinical outcomes
Author: Joynt, Gavin Matthew; Ling, Lowell; Wong, Wai Tat; Lipman, Jeffrey
Journal: EXPERT REVIEW OF CLINICAL PHARMACOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1080/17512433.2023.2194629
